Sharescart Research Club logo
Products
Research
Tools
About
ChatGPT Claude Perplexity
Summarize with
ChatGPT Claude Perplexity
Join Channel
Apollo Green₹ 72 (28.6%)ASK Investment₹ 895 (-3.2%)AVPL ₹ 49 (0%)Bootes Impex₹ 775 (-8.8%)CIAL ₹ 442 (-0.5%)CSK ₹ 254 (-3.1%)ESDS Software₹ 478 (2.8%)Garuda Aerospace₹ 468 (-2.1%)Goodluck Defence₹ 385 (16%)Hero Motors₹ 325 (0%)Hinduja Leyland₹ 248 (0%)ICL Fincorp₹ 25 (0%)Incred Holdings₹ 154 (2.7%)Kineco Limited₹ 3285 (0%)Lava ₹ 60 (15.4%)Market Simplified₹ 26 (-7.1%)Matrix Gas₹ 12 (-20%)Motilal Oswal₹ 12.25 (-2%)MSEI ₹ 6.35 (-2.3%)NCDEX ₹ 368 (-1.6%)NSE ₹ 1985 (-2%)Onix Renewable₹ 68 (21.4%)OYO ₹ 23 (-4.2%)OYO Assets₹ 9.25 (-7%)Philips India₹ 1250 (0%)Polymatech Electronics₹ 56 (-3.4%)SBI Mutual₹ 768 (-0.9%)Taparia Tools₹ 6050 (0%)VCI Chemical₹ 64 (0%)Zepto ₹ 40 (-4.8%)

15 Days Price Change

Gem Aromatics IPO

Closing In

  • days
  • Hours
  • Minutes
  • Seconds

WEBSITE Inc. Year: 1997 Industry: Chemicals Listed Page

Profile
Issue Size 317.93 Cr
Profile
Price Range 309  to  325 per share
Profile
Min Investment ₹325
Profile
Lot Size 1
Profile
Face Value ₹2
Profile
Draft Prospectus
Invest Before the IPO Goes Live

Buy unlisted shares early and participate in the growth before public listing.

Profile
  • Basic Info
  • IPO Tentative Timetable
  • IPO Lot Size
  • Subscription Status
  • Financials
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • Ratios
  • Growth Rates
  • Other info

Overview

We are an established manufacturer of specialty ingredients, including, essential oils, aroma chemicals and Value-Added Derivatives in India with a track record of over two decades. We offer a diversified portfolio of products, ranging from the Mother Ingredients to its various Value-Added Derivatives. Our products find application across a broad spectrum of industries, such as, oral care, cosmetics, nutraceuticals, pharmaceuticals, wellness and pain management and personal care. We are one of the prominent essential oils and Value-Added Derivatives manufacturers in India, based on value and volume manufactured, specializing in products that are derived from mint and clove oil. (Source: F&S Report) Our track record, diverse product portfolio and brand recall has helped us establish several leadership positions within our product portfolio, for instance, in India, we have a dominant presence in essential oil-based products and derivatives that are manufactured from mint, clove, eucalyptus oils and other essential oils. (Source: F&S Report) The largest segments under essential oil are – Orange oil, Mint oil, Clove oil, and Eucalyptus oil. We are present in three of the four major categories. (Source: F&S Report) During FY 2024 in India, we were the largest procurer of Piperita oil, and the largest processor of DMO, Clove oil, Eugenol and Eucalyptus Oil in terms of volume manufactured. (Source: F&S Report) As on FY 2024, our share of DMO and Eugenol in India was 11% and 62%, respectively, in terms of volume manufactured. Read More

Basic Info

Face Value 2 per share

Price 309  to  325 per share

P/E (x) 28.5

Sales( Cr.) 504

PAT( Cr.) 53

EPS 11.4

Draft Prospectus

Exchange BSE-NSE

Promoter

Company Promoters

Vipul Parekh Kaksha Vipul Parekh Yash Vipul Parekh Parekh Family Trust

Pre Issue Share Holding 75%

Post Issue Share Holding 55.06%

Listing Details:

Listing Price: 325

Listing Gain: 0%

Current Price: 148.4

Gain On Issue: 148.4 | 0%

GMP: --

GMP %: -- %

IPO Tentative Timetable

Opening Date Aug 19, 2025
Closing Date Aug 21, 2025
Allotment Aug 22, 2025
Refund Aug 25, 2025
Delivery of Shares Aug 25, 2025
Listing Date Aug 26, 2025

IPO Lot Size

Application Lots Shares Amount
Retail (Min) 1 46 14,950
Retail (Max) 13 598 194,350
S-HNI (Min) 14 644 209,300
S-HNI (Max) 66 3036 986,700
B-HNI (Min) 67 3082 1,001,650

Objective of the Issue

1.Prepayment and/or repayment, in full or in part, of all or a portion of certain outstanding borrowings availed by our Company and our Subsidiary, Krystal Ingredients Private Limited 2.General corporate purposes

Issue

Category Nos Bid Bid (x)
QIB 2700647 149290470 55.3x
NII 2124515 95730186 45.1x
Retail 4957201 51094546 10.3x
EMP 0 0 0x
Total 9782363 296115202 30.3x

Net Sales (in cr.)

Total Income (in cr.)

Operating Profit (in cr.)

Net Profit (in cr.)

Shareholder Funds (in cr.)

Total Assets (in cr.)

Gem Aromatics Profit & Loss

#(Fig in Cr.) Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM
Net Sales 314 425 452 504
Other Income 3 0 2 2
Total Income 317 425 454 506
Total Expenditure 265 359 374 416
Operating Profit 52 66 80 90
Interest 3 6 6 8
Depreciation 4 5 6 7
Exceptional Income / Expenses 0 0 0 0
Profit Before Tax 44 56 68 75
Provision for Tax 13 11 17 21
Profit After Tax 31 45 50 53
Adjustments 0 0 0 0
Profit After Adjustments 31 45 50 53
Adjusted Earnings Per Share 6.7 9.5 10.7 11.4

Gem Aromatics Balance Sheet

#(Fig in Cr.) Mar 2022 Mar 2023 Mar 2024 Mar 2025
Shareholder's Funds 138 180 231 284
Minority's Interest 0 0 0 0
Borrowings 0 0 24 69
Other Non-Current Liabilities 1 -0 -1 0
Total Current Liabilities 101 115 114 180
Total Liabilities 240 295 367 533
Fixed Assets 36 36 50 54
Other Non-Current Assets 2 15 37 135
Total Current Assets 202 244 280 343
Total Assets 240 295 367 533

Gem Aromatics Cash Flow

#(Fig in Cr.) Mar 2022 Mar 2023 Mar 2024 Mar 2025
Opening Cash & Cash Equivalents 8 6 11 16
Cash Flow from Operating Activities -5 15 40 -25
Cash Flow from Investing Activities -14 -14 -51 -93
Cash Flow from Financing Activities 18 6 15 103
Net Cash Inflow / Outflow -1 7 4 -15
Closing Cash & Cash Equivalent 6 11 16 1

Gem Aromatics Ratios

# Mar 2022 Mar 2023 Mar 2024 Mar 2025
Earnings Per Share (Rs) 6.66 9.53 10.69 11.39
CEPS(Rs) 7.58 10.55 12.03 12.96
DPS(Rs) 0 0 0 0
Book NAV/Share(Rs) 29.49 38.32 49.2 60.61
Core EBITDA Margin(%) 15.64 15.58 17.32 17.55
EBIT Margin(%) 15.1 14.53 16.33 16.43
Pre Tax Margin(%) 14.11 13.2 14.94 14.83
PAT Margin (%) 9.92 10.52 11.07 10.59
Cash Profit Margin (%) 11.3 11.64 12.46 12.05
ROA(%) 13.01 16.71 15.13 11.86
ROE(%) 22.57 28.12 24.44 20.75
ROCE(%) 22.07 25.51 24.2 19.53
Receivable days 45.88 51.19 50.41 67.47
Inventory Days 155.76 118.85 127.86 123.34
Payable days 26.79 22.21 21.43 20.46
PER(x) 0 0 0 0
Price/Book(x) 0 0 0 0
Dividend Yield(%) 0 0 0 0
EV/Net Sales(x) 0.23 0.19 0.23 0.46
EV/Core EBITDA(x) 1.39 1.21 1.3 2.55
Net Sales Growth(%) 0 35.14 6.51 11.38
EBIT Growth(%) 0 30.02 19.66 12.09
PAT Growth(%) 0 43.24 12.16 6.55
EPS Growth(%) 0 43.24 12.16 6.55
Debt/Equity(x) 0.56 0.5 0.48 0.78
Current Ratio(x) 2.01 2.12 2.47 1.91
Quick Ratio(x) 0.68 0.88 0.93 0.98
Interest Cover(x) 15.26 10.94 11.78 10.24
Total Debt/Mcap(x) 0 0 0 0

Sihora Industries Growth Rates

# 1 Year 3 Year 5 Year 10 Year
Sales CAGR 12% 17% 0% 0%
Operating Profit CAGR 13% 20% 0% 0%
PAT CAGR 6% 20% 0% 0%
# 1 Year 3 Year 5 Year 10 Year
Share Price CAGR NA% NA% NA% NA%
ROE Average 21% 24% 24% 24%
ROCE Average 20% 23% 23% 23%

Company Contact Information

Gem Aromatics Ltd.

Pooja Padam Bhandari

91 22 2518 5231

secretarial@gemaromatics.in

A/410, Kailas Complex Vikhroli Powai Link Road Park Site, Vikhroli (West)

IPO Lead Manager(s)

Gem Aromatics Ltd.

Motilal Oswal Investment Advisors Pvt Ltd

Registrar Info

Gem Aromatics Ltd.

K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)

Karvy Selenium Tower B, Plot 31-32 Gachibowli,Financial District, Nanakramguda Hyderabad – 500032 Tel. No. 040 67161500 Fax. No. 040 23001153 E-mail: einward.ris@karvy.com Website: www.karvy.com Toll Free No. of exclusive Call Centre:1-800-345001

040 - 67162222/18003094001

einward.ris@kfintech.com

https://www.kfintech.com

Frequently Asked Questions

All You Need To Know About IPO

When you leave without vesting, generally unvested ESOPs are cancelled. Vested ESOPs usually can be exercised after you depart, often within 3 to 6 months, depending on the company's ESOP plan.

For companies listed on a stock exchange, you can sell the shares any time after you exercise the ESOP option and the shares are in your demat account. If the company is unlisted or otherwise a startup, you can only sell the shares if and when the company announces a buyback or has a process for secondary sales.

Whenever you exercised your options to hold shares, you entered into a market risk situation, and if the valuation of the company drops, so do the shares.

Yes. ESOPs are valuable to the employer in that the employer is able to retain the best talent, align employee interests with company goals, and preserve cash while rewarding performance.

Wealth Icon
Don’t Miss Out on Unlisted Shares

Open your account today and gain instant access to top unlisted shares and pre-IPO opportunities.

whatsapp

Error!